Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CheMatech
Dijon, Bourgogne-Franche-Comté, France
- Ownership
- Private
- Development stage
- Other
01
Overview
CheMatech is the European leader in the design, synthesis, and GMP production of chelators (DOTA, NOTA and derivatives) for use in MRI contrast agents, PET and SPECT tracers, and theranostic radiopharmaceuticals, supporting both preclinical and clinical research worldwide
- Therapeutic areas
- OncologyOther
- Modalities
- Small moleculeChelatorBioconjugation reagent
- Industry
- Chemicals & Materials
02
Partnerships
Oncodesign (precision medicine/radiopharmaceutical development)Covalab (antibody and nanobody bioconjugation)ABX-CRO (clinical research and radiochemistry development)BioActs (distribution partnership for fluorescent probes)Guerbet (distribution of preclinical MRI probes)
Beyond the preview
Go deeper on CheMatech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CheMatech.